Hao Wang1, Yuxia Guan, Anne Lykkegaard Widlund, Lance B Becker, Joseph A Baur, Patrick M Reilly, Carrie A Sims. 1. From the Department of Critical Care Medicine (H.W.), Qilu Hospital of Shandong University, Jinan, China; The Trauma Center at Penn (H.W., Y.G., P.M.R., C.A.S.), University of Pennsylvania, Philadelphia, Pennsylvania; The Center for Resuscitation Science (Y.G., L.B.B., C.A.S.), University of Pennsylvania, Philadelphia, Pennsylvania; Institute for Diabetes, Obesity, and Metabolism and Department of Physiology (A.L.W., J.A.B., C.A.S.), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Science, Systems and Models (A.L.W.), Roskilde University, Roskilde, Denmark; Department of Emergency Medicine (L.B.B.), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Biochemistry and Molecular Biophysics Graduate Group (C.A.S.), University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract
BACKGROUND: Hemorrhagic shock (HS) may contribute to organ failure, by profoundly altering mitochondrial function. Resveratrol (RSV), a naturally occurring polyphenol, has been shown to promote mitochondrial function and regulate glucose homeostasis in diabetes. We hypothesized that RSV during resuscitation would ameliorate HS-induced mitochondrial dysfunction and improve hyperglycemia following acute blood loss. METHODS: With the use a decompensated HS model, male Long-Evans rats (n = 6 per group) were resuscitated with lactated Ringer's solution with or without RSV (30 mg/kg) and were killed before hemorrhage (sham), at severe shock, following resuscitation, and 18 hours after resuscitation. At each time point, the liver and kidney mitochondria were isolated to assess individual respiratory complexes (CI, CII, and CIV) and the production of reactive oxygen species (ROS). Blood samples were assayed for glucose, insulin, corticosterone, total glucagon-like peptide (GLP-1), glucagon, and serum cytokine levels. The Homeostatic Model Assessment-Insulin Resistance index was used to quantify insulin resistance. RESULTS: RSV supplementation following HS significantly improved mitochondrial function and decreased mitochondrial ROS production in both liver and kidney. RSV-treated animals had significantly lower blood glucose levels following resuscitation when compared with sham animals (116.0 ± 20.2 mg/dL vs. 227.7 ± 8.3 mg/dL, p < 0.05) or those resuscitated with lactated Ringer's solution (116.0 ± 20.2 mg/dL vs. 359.0 ± 79.5 mg/dL, p < 0.05). RSV supplementation was associated with significantly decreased plasma insulin levels (1.0 ± 0.4 ng/mL vs. 6.5 ± 3.7 ng/mL, p < 0.05), increased total GLP-1 levels (385.8 ± 56.6 ng/mL vs. 187.3 ± 11.1 ng/mL, p < 0.05), and a lower natural Log Homeostatic Model Assessment-Insulin Resistance index (1.30 ± 0.42 vs. 4.18 ± 0.68, p < 0.05) but had minimal effect on plasma corticosterone, glucagon, or cytokine levels. CONCLUSION: Resuscitation with RSV restores mitochondrial function and decreases insulin resistance but may be associated with increased hypoglycemia. The observed antiglycemic effects of RSV may be mediated by decreased mitochondrial ROS and increased GLP-1 secretion.
BACKGROUND:Hemorrhagic shock (HS) may contribute to organ failure, by profoundly altering mitochondrial function. Resveratrol (RSV), a naturally occurring polyphenol, has been shown to promote mitochondrial function and regulate glucose homeostasis in diabetes. We hypothesized that RSV during resuscitation would ameliorate HS-induced mitochondrial dysfunction and improve hyperglycemia following acute blood loss. METHODS: With the use a decompensated HS model, male Long-Evans rats (n = 6 per group) were resuscitated with lactated Ringer's solution with or without RSV (30 mg/kg) and were killed before hemorrhage (sham), at severe shock, following resuscitation, and 18 hours after resuscitation. At each time point, the liver and kidney mitochondria were isolated to assess individual respiratory complexes (CI, CII, and CIV) and the production of reactive oxygen species (ROS). Blood samples were assayed for glucose, insulin, corticosterone, total glucagon-like peptide (GLP-1), glucagon, and serum cytokine levels. The Homeostatic Model Assessment-Insulin Resistance index was used to quantify insulin resistance. RESULTS:RSV supplementation following HS significantly improved mitochondrial function and decreased mitochondrial ROS production in both liver and kidney. RSV-treated animals had significantly lower blood glucose levels following resuscitation when compared with sham animals (116.0 ± 20.2 mg/dL vs. 227.7 ± 8.3 mg/dL, p < 0.05) or those resuscitated with lactated Ringer's solution (116.0 ± 20.2 mg/dL vs. 359.0 ± 79.5 mg/dL, p < 0.05). RSV supplementation was associated with significantly decreased plasma insulin levels (1.0 ± 0.4 ng/mL vs. 6.5 ± 3.7 ng/mL, p < 0.05), increased total GLP-1 levels (385.8 ± 56.6 ng/mL vs. 187.3 ± 11.1 ng/mL, p < 0.05), and a lower natural Log Homeostatic Model Assessment-Insulin Resistance index (1.30 ± 0.42 vs. 4.18 ± 0.68, p < 0.05) but had minimal effect on plasma corticosterone, glucagon, or cytokine levels. CONCLUSION: Resuscitation with RSV restores mitochondrial function and decreases insulin resistance but may be associated with increased hypoglycemia. The observed antiglycemic effects of RSV may be mediated by decreased mitochondrial ROS and increased GLP-1 secretion.
Authors: H Sandhu; S R Wiesenthal; P E MacDonald; R H McCall; V Tchipashvili; S Rashid; M Satkunarajah; D M Irwin; Z Q Shi; P L Brubaker; M B Wheeler; M Vranic; S Efendic; A Giacca Journal: Diabetes Date: 1999-05 Impact factor: 9.461
Authors: Casey L Quinlan; Adam L Orr; Irina V Perevoshchikova; Jason R Treberg; Brian A Ackrell; Martin D Brand Journal: J Biol Chem Date: 2012-06-11 Impact factor: 5.157
Authors: Zoltan Ungvari; William E Sonntag; Rafael de Cabo; Joseph A Baur; Anna Csiszar Journal: Exerc Sport Sci Rev Date: 2011-07 Impact factor: 6.230
Authors: Joseph P Minei; Joseph Cuschieri; Jason Sperry; Ernest E Moore; Michael A West; Brian G Harbrecht; Grant E O'Keefe; Mitchell J Cohen; Lyle L Moldawer; Ronald G Tompkins; Ronald V Maier Journal: Crit Care Med Date: 2012-04 Impact factor: 7.598
Authors: Carrie A Sims; Yuxia Guan; Sarmistha Mukherjee; Khushboo Singh; Paul Botolin; Antonio Davila; Joseph A Baur Journal: JCI Insight Date: 2018-09-06
Authors: Carrie A Sims; Guan Yuxia; Khushboo Singh; Evan C Werlin; Patrick M Reilly; Joseph A Baur Journal: PLoS One Date: 2017-10-24 Impact factor: 3.240
Authors: Kumar Subramani; Sumin Lu; Marie Warren; Xiaogang Chu; Haroldo A Toque; R William Caldwell; Michael P Diamond; Raghavan Raju Journal: Sci Rep Date: 2017-06-01 Impact factor: 4.379